Caitlin Cameron
Chief Executive Officer at Otonexus Medical Technologies, Inc.
Caitlin Cameron active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Washington Biotechnology & Biomedical Association | Director/Board Member | 2014-06-30 | - |
Otonexus Medical Technologies, Inc.
 Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Chief Executive Officer | 2011-12-31 | - |
| Chairman | 2011-12-31 | - | |
| President | 2011-12-31 | - |
Career history of Caitlin Cameron
Former positions of Caitlin Cameron
| Companies | Position | Start | End |
|---|---|---|---|
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Chief Executive Officer | 2010-07-26 | - |
Statistics
International
| United States | 4 |
Operational
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association |
- Stock Market
- Insiders
- Caitlin Cameron
- Experience
